amelubant
Small moleculeexperimental
Clinical trial activity
18 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1998 (NCT02265302)
Timeline
Indications
Mechanism of action
- Leukotriene B4 receptor 1ANTAGONIST
LTB4R antagonist
Active metabolites are BIIL 260 and BIIL 315
Chemistry & pharmacology
Loading structure…
SMILES
CCOC(=O)NC(=N)c1ccc(OCc2cccc(COc3ccc(C(C)(C)c4ccc(O)cc4)cc3)c2)cc1- Mol. weight
- 538.64 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1742420 ↗
Also known as
- ((4-((3-((4-(1-(4-hydroxyphenyl)-1-methylethyl)phenoxy)methyl)phenyl)methoxy)phenyl)iminomethyl)carbamic acid ethyl ester
- amelubant
- amelubant
- amelubant
- biil 283 bs
- biil 283 bs
- biil 284
- biil-284
- biil-284
- biil-284
- biil 284 bs
- biil 284 bs
- biil 284 bs
- biil-284 bs
- biil-284-bs
- biil-284-bs
- ls-49968
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00060801 | Phase 2 | May 1, 2003 | Boehringer Ingelheim |
| NCT02269189 | Phase 1 | Apr 1, 2002 | Boehringer Ingelheim |
| NCT02265679 | Phase 1 | Oct 1, 2001 | Boehringer Ingelheim |
| NCT02265666 | Phase 1 | Oct 1, 2001 | Boehringer Ingelheim |
| NCT02251210 | Phase 2 | May 1, 2001 | Boehringer Ingelheim |
| NCT02249247 | Phase 2 | Apr 1, 2001 | Boehringer Ingelheim |
| NCT02265640 | Phase 1 | Oct 1, 2000 | Boehringer Ingelheim |
| NCT02273440 | Phase 1 | May 1, 2000 | Boehringer Ingelheim |
| NCT02268149 | Phase 1 | Apr 1, 2000 | Boehringer Ingelheim |
| NCT02265627 | Phase 1 | Mar 1, 2000 | Boehringer Ingelheim |
| NCT02273427 | Phase 1 | Feb 1, 2000 | Boehringer Ingelheim |
| NCT02247375 | Phase 1 | Jan 1, 2000 | Boehringer Ingelheim |
| NCT02265653 | Phase 1 | Nov 1, 1999 | Boehringer Ingelheim |
| NCT02249338 | Phase 2 | Oct 1, 1999 | Boehringer Ingelheim |
| NCT02266550 | Phase 1 | Oct 1, 1999 | Boehringer Ingelheim |
| NCT02249312 | Phase 2 | Jul 1, 1999 | Boehringer Ingelheim |
| NCT02273414 | Phase 1 | Jul 1, 1999 | Boehringer Ingelheim |
| NCT02265302 | Phase 1 | Jun 1, 1998 | Boehringer Ingelheim |
Showing 18 of 18 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 18 | 18 | 2 | 1998 |
1 organizations
Page 1 / 1